Covid: hopes for Oxford nasal vaccine dealt blow after poor trial results

Scientists ditch plans to develop nasal spray version of Oxford/AstraZeneca vaccine in its current formHopes of distributing the Oxford/AstraZeneca Covid vaccine as anasal spray have been dealt a blow after researchers said it performed poorly in its first clinical trial.The underwhelming results have led scientists to abandon plans to develop the spray in its current form, with hopes now resting on different formulations of the vaccine and more complex delivery devices, such as nebulisers that can deliver medicines deep into the lungs.Continue reading...

Source: Guardian Unlimited Science - October 10, 2022 Category: Science Authors: Ian Sample Science editor Tags: Coronavirus Vaccines and immunisation Science Health World news Society Infectious diseases University of Oxford AstraZeneca Medical research Microbiology Pharmaceuticals industry Source Type: news